Category Archives: Topical Dutasteride

Brief Items of Interest, April 2017

Hair loss news first:

— A great story on Dr. Rox Anderson that was also retweeted by PureTech CEO Daphne Zohar:

In the article, Mr. Anderson is praised by the famous hair loss researcher Dr. George Cotsarelis as being a modern day Dr. Benjamin Franklin. Several people that I highly respect have in the past recommended my reading Dr. Franklin’s autobiography, but the one time I tried, I fell asleep very soon after commencing. If I recall correctly, the English was a bit antiquated and difficult to comprehend in my edition.

— Of the numerous companies working on hair growth related products around the world, US based Samumed has been by far and away the best at getting coverage in major print and online publications. This month, they appeared in Business Insider. Dr. Osman Kibar, the CEO of Samumed, is a great poker player. I hope that he is not bluffing the world in real life too. Key quote:

The $12 billion valuation Samumed has right now is based on the $300 million it has raised over the years. The valuation grew based on its lead compound, with the rest of the pipeline thrown in as a “freebie,” Kibar said.

The Business Insider article became a very popular discussion topic on reddit with some interesting comments. Samumed also appeared in Forbes magazine yet again at the beginning of this month.

— Every 6 months or so, the highly unusual case study known as Mr. “Peter Renardo” posts updates in the comments in here. I still insist never ever even considering such an extreme artery ligature procedure, but do make sure to read Peter’s comments.

Topical Dutasteride would be something that I would seriously consider (h/t commentator “Hairplz”).

— Most people’s favorite hair loss researcher Dr. Takashi Tsuji recently came out with a new study/paper titled “Functional Hair Follicle Regeneration by the Rearrangement of Stem Cells”. However, it is in mice and perhaps not especially groundbreaking (see the 5 or so comments in here after “Paul Phoenix” ‘s comment with the study link in there from April 1 at 12:36 pm — you might see a different time in there depending on your location).

— As if it were not enough that hair loss is connected to higher rates of heart disease (“bing” it), it seems like grey hair might also be linked to higher rates of heart disease. Quote: “Atherosclerosis and hair greying occur through similar biological pathways”.

— When I read this article a week ago, I was certain that it was an exaggeration or a translation error. I contacted HairClone CEO Dr. Paul Kemp and he said that the company’s plans remain the same as outlined in his earlier comments on this blog from a few months ago. In any case, if you have any questions about HairClone, you can ask in the comments to this post and Dr. Kemp will come by and respond when he has some free time. Alternatively, you can ask in this thread on hairsite. And no, hair cloning is definitely not yet here in spite of flashy article titles.

Jason McAteer hair transplant.

And now on to medical items of interest:

— I covered the much hyped skin gun and its inventor Dr. Jörg Gerlach on this blog before (see 2011 video here). I was glad to read a new article on this as I thought that RenovaCare might have given up on this technology.

www.AcneCure2020.com anyone?

— Japan is becoming renowned for medical research, not surprising considering its aging population. A Japanese man recently became the first to receive “reprogrammed” stem cells from another person.

— After reading this post (and a few others on this blog), you might think that I am a very biased Japanophile. However, this is not true…and I had to insert that disclaimer before I included the following Japan focused thought here:

For many years, I have noticed that each time the oldest person in the world died, virtually half the time it was a Japanese person. Of course since birth certificates were nonexistent in most developing countries 100 plus years ago, these statistics are biased towards people from developed countries. Nevertheless, after the oldest person (who I covered on this blog in the past) in the world died yesterday, I went to the the wikipedia list of supercentenarians, and lo an behold, 5 of the oldest 10 people in the world at the moment are Japanese.

Interesting article on extending lifespan.

Update on developing pig organs for human transplants.

Half man, half machine.

— US and Chinese teams collaborate and expand stem cell abilities.

CRISPR gene editing to supercharge agriculture.

Dr. Victor Hasson updates us on topical finasteride and topical dutasteride

I wrote a popular post on topical finasteride in June 2014.   Shorly after, someone from the renowned Hasson & Wong clinic in Vancouver, Canada e-mailed me to let me know that they were now prescribing topical Finasteride.

Fast forward to several days ago, Dr. Victor Hasson of Hasson & Wong posted a detailed comment to that blog post on topical finasteride and I thought that his comment deserved its own post. Here is Dr. Hasson’s update:

Our topical Finasteride solution that we have been using for the past 2 years has proven to be very effective . It has been used primarily in patients who had been experiencing side effects on the oral drug. These patients have been free of side effects on the topical formulation. This is a good sign that the drug is unlikely to be going systemic via cutaneous permeation. We are currently performing tests using Franz diffusion cells with the The University of Milan to get more data.

Once we have secured a reliable source for Dutasteride we will start testing topical formulations with this drug as it will likely be more effective.

A new liposomal formulation of topical finasteride is currently available to our European patients. It has been developed in collaboration with Farmacia Parati in Italy. This preparation can be obtained from this company . You will require a physicians prescription for this as the formulation needs to be compounded on a case by case basis (to comply with European and FDA regulations).

Victor Hasson MD

I am impressed by the efforts that the Hassson & Wong clinic is putting into creating their own topical finasteride and topical dutasteride products.  A 2007 study on liposomal delivery of Finasteride suggests that this route  will be effective.  If the results from these topical products consistently prove to be as good or superior to oral finasteride and oral dutasteride while at the same time lead to fewer side effects, this development will be a game changer.